News

Article

PTSM: Pharmaceutical Technology Sourcing and Management

PTSM: Pharmaceutical Technology Sourcing and Management

PTSM: Pharmaceutical Technology Sourcing and Management-11-02-2016
Volume11
Issue 11

Recipharm to Open New GLP Bioanalysis Laboratory in Sweden

Recipharm announced that it has invested 5 million SEK in a new GLP bioanalysis laboratory in Uppsala.

On Oct. 17, 2016, Recipharm announced a 5-million SEK (approximately $566,546.50) investment in a new GLP compliant bioanalysis laboratory at its development facility in Uppsala, Sweden, in response to growing customer demand. The 500-square-meter facility is expected to open in November 2016. According to Recipharm, this facility will become the largest GLP bioanalysis laboratory of its kind in the Nordic countries.

Recipharm’s development team in Uppsala specializes in medicinal chemistry, offering synthesis and analytical preclinical development services to drug-development companies progressing products through clinical trials. This new laboratory will allow Recipharm to increase its capacity, with the capability to process more than 10,000 plasma samples per week. In order to support the increasing demand of bioanalysis services, Recipharm Development in Uppsala plans to recruit several new PhD-level chemists in the coming months and aims to more than double its team of 35 in the next couple of years.

“This is a strategic investment for Recipharm as there is a real need for more GLP bioanalysis laboratories in the Nordic region,” Fredrik Lehmann, general manager of Recipharm Development in Uppsala said in a statement. “Bioanalysis requires specialist expertise and establishing the necessary capabilities can be a costly investment, proving a barrier to entry for many contract services providers. Having first started out in a collaboration with a subcontractor, we are now delighted to be able to expand our offering in-house to service an unmet need for bioanalysis capabilities.”

Source: Recipharm

 

Newsletter

Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.

Related Videos
A global supply chain map, visualizing the complex network of transportation routes and distribution centers | Image Credit: © venusvi - stock.adobe.com
Shortcut from point A to point B | Image Credit: © Olivier Le Moal - stock.adobe.com
Behind the Headlines, Episode 21: Waters-BD Merger, Merck’s $10B Bet, and Biotech’s Investment Frontiers
Wooden blocks spelling TARIFFS are placed on a map of North America, specifically over the United States and Mexico | Image Credit: © Rokas - stock.adobe.com
Jason Waite, International Trade Expert, Alston & Bird
Simona Guidi, Associate Director, ProPharma
Tore Bergsteiner
Behind the Headlines, Episode 20: CAR-T Milestones, Abbvie and Eli Lilly M&A Moves, and More
Related Content